Rhino Maxillary Mucormycosis During the Covid-19 Third Wave: A Case Report
Description
- With the surge of cases during the third wave of COVID-19, India faced a number of Mucormycosis cases, a rare but potentially fatal fungal infection, caused by the mucormycetes. The increased prevalence of Mucormycosis among COVID-19 patients may be associated with increased use of steroids, or the possible immunocompromised state caused by SARS-CoV2 or coexisting conditions such as diabetes mellitus. Presenting a case of Rhinomaxillary Mucormycosis where patient presented with a complaint of ulcerative lesion on palate. A diagnosis of Mucormycosis was established after Contrast Enhanced Computed Tomography (CECT) and cytology. Management was planned with antifungal therapy and surgical intervention. Due to immunocompromised state patient couldn’t survive
Files
IJISRT23FEB1237.pdf
Files
(497.8 kB)
| Name | Size | Download all |
|---|---|---|
|
md5:cc3e2c16089ac8f2834d80bcb2e13e36
|
497.8 kB | Preview Download |